CGRP inhibits proliferation, activation and cytokine secretion of group 2 innate lymphoid cells (ILC2) in peripheral blood from patients with allergic rhinitis.
- Author:
Hedi ZHUO
1
;
Xueping QI
1
;
Nuowen XU
1
;
Yanjie WANG
2
;
Yunfang AN
2
;
Jinmei XUE
2
;
Changqing ZHAO
3
Author Information
1. Shanxi Medical University, Department of Otolaryngology, Head and Neck Surgery, Shanxi Medical University Second Affiliated Hospital, Key Research Laboratory of Airway Neuroimmunology, Taiyuan 030000, China.
2. Department of Otolaryngology, Head and Neck Surgery, Shanxi Medical University Second Affiliated Hospital, Key Research Laboratory of Airway Neuroimmunology, Taiyuan 030000, China.
3. Department of Otolaryngology, Head and Neck Surgery, Shanxi Medical University Second Affiliated Hospital, Key Research Laboratory of Airway Neuroimmunology, Taiyuan 030000, China. *Corresponding author, E-mail: fahyj@126.com.
- Publication Type:Journal Article
- MeSH:
Humans;
Calcitonin Gene-Related Peptide/pharmacology*;
Leukocytes, Mononuclear;
Immunity, Innate;
Interleukin-33/pharmacology*;
Interleukin-13;
Lymphocytes;
Interleukin-5/pharmacology*;
Rhinitis, Allergic;
Cell Proliferation
- From:
Chinese Journal of Cellular and Molecular Immunology
2023;39(12):1094-1099
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of calcitonin gene-related peptide (CGRP) on the regulation of group 2 innate lymphoid cells (ILC2) in the peripheral blood of patients with allergic rhinitis (AR). Methods Peripheral blood mononuclear cells (PBMCs) were extracted from normal healthy individuals and AR patients, then stimulated with CGRP, interleukin 33 (IL-33) and CGRP combined with IL-33 for 3 days, with blank stimulus as control. The percentage of ILC2 in the four groups was measured by flow cytometry. After being sorted, ILC2 was given to CGRP, IL-33 and CGRP combined with IL-33 stimulation for 3 days, with blank stimulus as control. The percentage of IL-5 and IL-13 positive cells in ILC2 was detected by flow cytometry, and the levels of IL-5 and IL-13 in ILC2 supernatant were measured by ELISA. Results The percentage of ILC2 in the peripheral blood of AR patients was significantly higher than that of the control group. The levels of IL-5+ILC2 and IL-13+ILC2 were significantly increased by IL-33 single stimulation after culturing PBMCs. After adding IL-33 combined with CGRP stimulation, the levels of IL-5+ILC2 and IL-13+ILC2 in PBMCs were significantly reduced; after CGRP single stimulation, the levels of IL-5+ILC2 and IL-13+ILC2 in PBMCs were further decreased. After ILC2 was sorted and cultured, the levels of IL-5+ILC2 and IL-13+ILC2 showed significant increase after IL-33 single stimulation. The levels of IL-5+ILC2 and IL-13+ILC2 were decreased by IL-33 and CGRP co-stimulation, and they were further reduced after CGRP single stimulation. Compared to IL-33 single stimulation, IL-5 and IL-13 levels dropped significantly due to the IL-33 and CGRP co-stimulation. The levels of IL-5 and IL-13 were further reduced by CGRP single stimulation. Conclusion CGRP inhibits the proliferation and activation of peripheral blood ILC2 in AR and exert anti-inflammatory effects in AR.
